AJEM Live

In this episode, AJEM speaks with Heike Schön, Co-founder and Managing Director of Berlin-based Lumis International, about conducting medical cannabis clinical trials in Europe. Visit us at endocannabinoidmedicine.com

In this episode, AJEM speaks with Uwe Blesching, PhD, Co-Founder and Chief Science Officer at CannaKeys, an app and online platform that he designed to demystify the science of the endocannabinoid system. Visit us at endocannabinoidmedicine.com

In this episode, AJEM speaks with Miri Ogintz, RN, Director of the Cannabis Clinic at Rambam Hospital in Haifa, Israel, who is seeing an increase in mental health symptoms and a high demand for medical cannabis. Visit us at endocannabinoidmedicine.com

In this episode, AJEM speaks with Silviu Brill, MD, Director of the Pain Institute at Tel Aviv Sourasky Medical Center and co-organizer of the the 4th International Annual Congress on Controversies on Cannabis-Based Medicines, which took place in Frankfurt, Germany Medical Cannabis. Visit us at endocannabinoidmedicine.com

In this episode, AJEM speaks with Michelle Roche, PhD, BSc, MSc, an Associate Professor and Neuroscientist in Physiology at the University of Galway on Ireland’s west coast, about the endocannabinoid system and autism spectrum disorder. Visit us at endocannabinoidmedicine.com

In this episode, AJEM speaks with Sara Jane Ward, PhD, Associate Professor at the Center for Substance Abuse Research at Temple University’s Lewis Katz School of Medicine in Philadelphia, Pennsylvania, about the research she conducts on cannabinoid-based therapies for pain. Visit us at endocannabinoidmedicine.com

Visit us at endocannabinoidmedicine.com

In this episode, AJEM's Senior Managing Editor and Brand Director speak with attorney EricPostow about cannabis law and the SAFER Banking Act.Visit us at endocannabinoidmedicine.com Visit us at endocannabinoidmedicine.com

In this episode, AJEM speaks with Henrik Jungaberle, Dr. sc. hum., Executive Director of the Berlin, Germany-based MIND Foundation about how psychedelic medicine is finally gaining acceptance in the mainstream medical community. He discusses how we are still recovering from the 1960's narrative of ‘seeing psychedelics as super-therapy’ and advocates for well-trained therapists who can see both the pitfalls and potential of psychedelic medicine.    Visit us at endocannabinoidmedicine.com Visit us at endocannabinoidmedicine.com

In this episode, AJEM talks with Hinanit Koltai, PhD, a Senior Research Scientist at Israel’s Volcani Institute, about her research showing the potential of cannabinoid-based therapy for the treatment of ovarian cancer. Visit us at endocannabinoidmedicine.com Visit us at endocannabinoidmedicine.com

In this episode, AJEM is broadcasting from Berlin's MIND Foundation INSIGHT ‘23 meeting with Matt Johnson, PhD, a Professor of Psychiatry and Behavioral Science at Johns Hopkins University School of Medicine in Baltimore. At the meeting, Dr. Johnson gave a presentation entitled, "Preparing of Approved Psychedelic Medicine: Dangerous Trajectories in Psychedelic Science." Visit us at endocannabinoidmedicine.com Visit us at endocannabinoidmedicine.com

In this episode, AJEM shines a light on Staci Gruber, PhD, Director of the Cognitive and Clinical Neuroimaging Core and Director of the Marijuana Investigations for Neuroscientific Discovery (MIND) program at McLean Hospital, in Belmont, Massachusetts, and an Associate Professor of Psychiatry at Harvard Medical School in Cambridge.Visit us at endocannabinoidmedicine.com Visit us at endocannabinoidmedicine.com

In this episode, AJEM talks with Professor Yossi Tam, DMD, PhD, MSc, BMedSc, Director Israel's Multidisciplinary Center for Cannabinoid Research, about his lengthy career in cannabis research.  Visit us at endocannabinoidmedicine.com Visit us at endocannabinoidmedicine.com

In this episode, AJEM talks with Australia's former Deputy Health Minister Professor John Skerritt, PhD, about the lessons learned from medical cannabis as Australia becomes the first nation to legalize psilocybin and MDMA to treat depression and PTSD. Visit us at endocannabinoidmedicine.com Visit us at endocannabinoidmedicine.com

In this episode, AJEM talks with Integrative Medicine Physician Dustin Sulak, DO, about the merits of low- and ultra-low doses of cannabinoid-based therapy. Visit us at endocannabinoidmedicine.com Visit us at endocannabinoidmedicine.com

In this episode, AJEM talks with Israeli Pediatric Neurologist Adi Aran, MD, about his latest study on cannabinoid-based therapy for children with autism spectrum disorder. Visit us at endocannabinoidmedicine.com Visit us at endocannabinoidmedicine.com

In this episode, AJEM's Editor in Chief, Senior Managing Editor and Brand Director talk about challenges and opportunities for the journal and what led them to AJEM in the first place. Visit us at endocannabinoidmedicine.com Visit us at endocannabinoidmedicine.com

In this episode, clinical cannabis pharmacist Stacia Woodcock, PharmD, talks with AJEM's Editor-in-Chief Leslie Apgar, MD, about dosing, administration, and polypharmacy. Dr. Woodcock is currently working as a Pharmacy Editor for GoodRx Health. She delights in using her clinical expertise to help educate practitioners, patients, and communities in an effort to remove the pervasive stigma surrounding cannabis as medicine. Visit us at endocannabinoidmedicine.com Visit us at endocannabinoidmedicine.com

In this episode, we talk with Harvard-trained Peter Grinspoon, MD, about the potential for cannabinoids to treat substance use disorder in physicians. Be sure to listen to the end, where Dr. Grinspoon recounts a personal story with legendary astronomer and 'Cosmos' author Carl Sagan. Visit us at endocannabinoidmedicine.com Visit us at endocannabinoidmedicine.com

In this episode, clinical cannabis pharmacist Leah Johnson, PharmD, urges nationwide adoption of California's "Ryan's Law", which allows terminally ill patients to use medical cannabis in a hospital or other qualified medical care facility. Visit us at endocannabinoidmedicine.com Visit us at endocannabinoidmedicine.com

In this episode, we discuss the inclusion of cannabis medicine at the recent Global Health Catalyst Summit, which was held at the University of Pennsylvania, and the work that Dr. Carrillo is doing to support cannabis education efforts. Visit us at endocannabinoidmedicine.com Visit us at endocannabinoidmedicine.com

In this episode, we talk with Dedi Meiri, PhD, about early drug development and his Lab’s work with minor cannabinoids to treat cancer and diseases of the nervous and immune systems.Visit us at endocannabinoidmedicine.com Visit us at endocannabinoidmedicine.com

In this episode, we talk with Bonni Goldstein, MD, about the treatment of pediatric refractory epilepsy with medical cannabis. Visit us at endocannabinoidmedicine.com Visit us at endocannabinoidmedicine.com

Meet AJEM’s Editor in Chief, Leslie Apgar, MD! In this episode, Dr. Apgar describes her transition from obstetrics and gynecology to cannabis medicine. She also shares her passion for medical cannabis education and her hopes for the the journal. Visit us at endocannabinoidmedicine.com Visit us at endocannabinoidmedicine.com

In this episode, we discuss cannabinoid screening guidelines put forth by the American Society of Regional Anesthesia (ASRA) and Pain Medicine, with public health expert Theresa Simon, MPH.  Visit us at endocannabinoidmedicine.com Visit us at endocannabinoidmedicine.com

In this episode, we spotlight Takoma Park Integrative Care, a medical cannabis practice established by Patricia Frye, MD, in 2015. Dr. Frye shares her transition to cannabis medicine and her focus on pediatric autism. Visit us at endocannabinoidmedicine.com Visit us at endocannabinoidmedicine.com

In the inaugural episode of AJEM Live, Dr. Stacia Woodcock, a Doctor of Pharmacy and clinical cannabis pharmacist, discuses the nuances of CBD formulations. Dr. Woodcock is currently working as a Pharmacy Editor for GoodRx Health. She delights in using her clinical expertise to help educate practitioners, patients, and communities in an effort to remove the pervasive stigma surrounding cannabis as medicine.Visit us at endocannabinoidmedicine.com Visit us at endocannabinoidmedicine.com

The American Journal of Endocannabinoid Medicine welcomes you to AJEM Live, interviews with physicians on the frontlines of endocannabinoid medicine and scientists behind the industry's top research trials.   Visit us at endocannabinoidmedicine.com Visit us at endocannabinoidmedicine.com